FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

18290811000001108: Renagel 800mg tablets (Genzyme Therapeutics Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Dec 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
62623401000001110 Renagel 800mg tablets (Genzyme Therapeutics Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
68876701000001113 Renagel 800mg tablets (Sanofi) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Renagel 800mg tablets (Genzyme Therapeutics Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Renagel 800mg tablets (Genzyme Therapeutics Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Renagel 800mg tablets (Genzyme Therapeutics Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Renagel 800mg tablets (Genzyme Therapeutics Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Renagel 800mg tablets (Genzyme Therapeutics Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Renagel 800mg tablets (Genzyme Therapeutics Ltd) Is a Sevelamer 800mg tablets true Inferred relationship Existential restriction modifier
Renagel 800mg tablets (Genzyme Therapeutics Ltd) Has active ingredient Sevelamer true Inferred relationship Existential restriction modifier
Renagel 800mg tablets (Genzyme Therapeutics Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Renagel 800mg tablets (Genzyme Therapeutics Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Renagel 800mg tablets (Genzyme Therapeutics Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Renagel 800mg tablets (Genzyme Therapeutics Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Renagel 800mg tablets (Genzyme Therapeutics Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Renagel 800mg tablets (Genzyme Therapeutics Ltd) Is a Renagel true Inferred relationship Existential restriction modifier
Renagel 800mg tablets (Genzyme Therapeutics Ltd) Has specific active ingredient Sevelamer true Inferred relationship Existential restriction modifier
Renagel 800mg tablets (Genzyme Therapeutics Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Renagel 800mg tablets (Genzyme Therapeutics Ltd) 180 tablet Has AMP True Renagel 800mg tablets (Genzyme Therapeutics Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start